Glycosaminoglycan biosynthesis pathway (GAG biosynthesis) (GAG biosynthesis)

The glycosaminoglycan (GAG) biosynthesis pathway in dermal fibroblasts is a complex, multi-step enzymatic process responsible for producing long, unbranched polysaccharides that are essential components of the skin's extracellular matrix (ECM) (Gantwerker & Hom, 2011). These GAGs, which include hyaluronic acid, dermatan sulfate, and heparan sulfate, play a critical role in maintaining skin hydration, turgor, and structural integrity by binding water and interacting with structural proteins like collagen (Papakonstantinou et al., 2012). Dermal fibroblasts synthesize these molecules through the coordinated action of various enzymes, most notably hyaluronan synthases (HAS1, HAS2, HAS3) and xylosyltransferases (XYLT1, XYLT2), which initiate the synthesis of proteoglycan-linked GAG chains. Dysregulation of this pathway is a hallmark of skin aging and photoaging, as well as fibrotic conditions such as scleroderma, where altered GAG levels contribute to loss of elasticity or excessive tissue hardening (Kwan et al., 1997). Pharmacological modulation of GAG biosynthesis is a major focus in dermatology and aesthetics; for example, retinoids are used to stimulate GAG production to improve skin texture, while inhibitors like 4-methylumbelliferone are utilized in research to study the effects of hyaluronan depletion on tissue behavior (Röck et al., 2011).

Other names

Glycosaminoglycan synthesisMucopolysaccharide biosynthesisExtracellular matrix glycosaminoglycan metabolismGAG metabolic pathway